NCT01028924View on ClinicalTrials.gov

Effects of Teduglutide on Cardiac Repolarisation and Conduction in Healthy Male and Female Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

November 30, 2009

Primary Completion Date

February 28, 2010

Study Completion Date

April 30, 2010

Conditions
Healthy
Interventions
DRUG

Teduglutide

subcutaneous (SC), single dose

Trial Locations (1)

78467

Nycomed GmbH, Konstanz

Sponsors

Lead Sponsor

Nycomed
All Listed Sponsors
lead

Nycomed

INDUSTRY

NCT01028924 - Effects of Teduglutide on Cardiac Repolarisation and Conduction in Healthy Male and Female Volunteers | Biotech Hunter | Biotech Hunter